Pharmsville Co., Ltd. (KOSDAQ:318010)
3,575.00
+10.00 (0.28%)
At close: May 29, 2026
Pharmsville Revenue
Pharmsville had revenue of 2.49B KRW in the quarter ending March 31, 2026, a decrease of -25.51%. This brings the company's revenue in the last twelve months to 11.88B, down -22.22% year-over-year. In the year 2025, Pharmsville had annual revenue of 12.73B, down -23.90%.
Revenue (ttm)
11.88B
Revenue Growth
-22.22%
P/S Ratio
2.33
Revenue / Employee
424.17M
Employees
28
Market Cap
27.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.73B | -4.00B | -23.90% |
| Dec 31, 2024 | 16.72B | -4.67B | -21.83% |
| Dec 31, 2023 | 21.39B | -4.72B | -18.07% |
| Dec 31, 2022 | 26.11B | -12.91B | -33.09% |
| Dec 31, 2021 | 39.03B | -381.05M | -0.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 99.01B |
| GeneBioTech Co. ,Ltd | 89.44B |
| Korean Drug | 62.76B |
| ChoA Pharmaceutical Co., LTD. | 59.62B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 51.33B |
| Union Korea Pharm | 29.66B |
| Daesung Microbiological Labs. | 25.87B |